美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Zura Bio

1.64

-0.0400-2.38%

盘后：1.63-0.0100-0.61%19:56 EDT

成交量：46.54万

成交额：77.78万

市值：1.01亿

市盈率：-2.29

高：1.75

开：1.68

低：1.62

收：1.68

数据加载中...

总览公司新闻公告

Zura Bio Limited2025财年第一财季实现净利润-17.44百万美元，同比减少2289.04%

Zura Bio Limited盘中异动下午盘快速下挫5.00%报1.14美元

Zura Bio Limited盘中异动下午盘股价大跌5.37%

Zura Bio Limited盘中异动早盘股价大涨5.79%报1.28美元

奥本海默：维持Zura Bio(ZURA.US)评级，由优于大市调整至优于大市评级, 目标价由19.00美元调整至17.00美元。

祖拉生物有限公司公布截至 3 月 31 日的季度业绩 - 收益摘要

Zura Bio Limited盘中异动股价大跌5.56%报1.36美元

Zura Bio Ltd 预计每股亏损15美分 - 财报前瞻

Zura Bio Limited盘中异动早盘股价大跌5.16%报1.46美元

Zura Bio Limited盘中异动大幅上涨5.04%报1.46美元

Zura Bio Limited盘中异动下午盘快速跳水5.21%报1.37美元

Zura Bio Limited盘中异动急速上涨5.03%报1.57美元

Zura Bio Limited盘中异动早盘大幅上涨5.11%

Zura Bio Limited盘中异动早盘急速上涨5.69%

Zura Bio Limited盘中异动快速拉升5.04%

Zura Bio Limited盘中异动股价大涨5.35%

Zura Bio Limited盘中异动股价大跌6.20%报1.14美元

Zura Bio Limited盘中异动股价大涨5.36%

Zura Bio Limited盘中异动股价大跌6.56%报1.14美元

Zura Bio Limited盘中异动大幅上涨5.31%

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/ZURA/news?page=2"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ZURA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ZURA\",,,,,undefined,":{"symbol":"ZURA","market":"US","secType":"STK","nameCN":"Zura Bio","latestPrice":1.64,"timestamp":1753473600000,"preClose":1.68,"halted":0,"volume":465397,"hourTrading":{"tag":"盘后","latestPrice":1.63,"preClose":1.64,"latestTime":"19:56 EDT","volume":1038,"amount":1695.46,"timestamp":1753487790418},"delay":0,"floatShares":24675037,"shares":61874998,"eps":-0.717206,"marketStatus":"休市中","change":-0.04,"latestTime":"07-25 16:00:00 EDT","open":1.684,"high":1.7497,"low":1.62,"amount":777768.8136371,"amplitude":0.077202,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.717206,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1753689600000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":1.68,"preHourTrading":{"tag":"盘前","latestPrice":1.68,"preClose":1.68,"latestTime":"09:19 EDT","volume":827,"amount":1425.3800677,"timestamp":1753449554996},"postHourTrading":{"tag":"盘后","latestPrice":1.63,"preClose":1.64,"latestTime":"19:56 EDT","volume":1038,"amount":1695.46,"timestamp":1753487790418},"volumeRatio":0.4197963690731072,"impliedVol":0.5813,"impliedVolPercentile":0.1814},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ZURA\",,,,,undefined,":{"symbol":"ZURA","floatShares":24675037,"roa":"-31.40%","roe":"-55.05%","lyrEps":-0.604576,"volumeRatio":0.4197963690731072,"shares":61874998,"dividePrice":0,"high":1.7497,"amplitude":0.077202,"preClose":1.68,"low":1.62,"week52Low":0.97,"pbRate":"0.73","week52High":5.07,"institutionHeld":0,"latestPrice":1.64,"eps":-0.717206,"divideRate":0,"volume":465397,"delay":0,"ttmEps":-0.717206,"open":1.684,"prevYearClose":2.5,"prevWeekClose":1.91,"prevMonthClose":1.05,"prevQuarterClose":1.05,"fiveDayClose":1.91,"twentyDayClose":1.15,"sixtyDayClose":1.39},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ZURA\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2536582446","title":"Zura Bio Limited2025财年第一财季实现净利润-17.44百万美元，同比减少2289.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536582446","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536582446?lang=zh_cn&edition=fundamental","pubTime":"2025-05-18 00:00","pubTimestamp":1747497611,"startTime":"0","endTime":"0","summary":"5月18日，Zura Bio Limited公布财报，公告显示公司2025财年第一财季净利润为-17.44百万美元，同比减少2289.04%；其中营业收入为0.00美元，每股基本收益为-0.19美元。从资产负债表来看，Zura Bio Limited总负债21.09百万美元，其中短期债务0.00美元，资产负债比为0.09，流动比率为0.09。机构评级：截至2025年5月18日，当前有6家机构对Zura Bio Limited目标价做出预测，其中目标均价为13.67美元，其中最低目标价为3.00美元，最高目标价为26.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250518000023a6e2d79c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250518000023a6e2d79c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZURA"],"gpt_icon":0},{"id":"2536346241","title":"Zura Bio Limited盘中异动 下午盘快速下挫5.00%报1.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536346241","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536346241?lang=zh_cn&edition=fundamental","pubTime":"2025-05-17 01:27","pubTimestamp":1747416428,"startTime":"0","endTime":"0","summary":"北京时间2025年05月17日01时27分，Zura Bio Limited股票出现异动，股价急速下跌5.00%。截至发稿，该股报1.14美元/股，成交量94.3261万股，换手率1.52%，振幅7.50%。Zura Bio Limited股票所在的生物技术行业中，整体涨幅为0.55%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517012708aa2c91b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517012708aa2c91b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZURA"],"gpt_icon":0},{"id":"2535009879","title":"Zura Bio Limited盘中异动 下午盘股价大跌5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535009879","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535009879?lang=zh_cn&edition=fundamental","pubTime":"2025-05-15 02:13","pubTimestamp":1747246420,"startTime":"0","endTime":"0","summary":"北京时间2025年05月15日02时13分，Zura Bio Limited股票出现异动，股价大幅下跌5.37%。截至发稿，该股报1.15美元/股，成交量14.029万股，换手率0.21%，振幅6.20%。Zura Bio Limited股票所在的生物技术行业中，整体跌幅为1.22%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051502134094f6fa33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051502134094f6fa33&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZURA","BK4139"],"gpt_icon":0},{"id":"2534766102","title":"Zura Bio Limited盘中异动 早盘股价大涨5.79%报1.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534766102","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534766102?lang=zh_cn&edition=fundamental","pubTime":"2025-05-12 21:32","pubTimestamp":1747056763,"startTime":"0","endTime":"0","summary":"北京时间2025年05月12日21时32分，Zura Bio Limited股票出现波动，股价急速上涨5.79%。Zura Bio Limited股票所在的生物技术行业中，整体涨幅为0.32%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。消息层面，截至21时32分，《奥本海默：维持Zura Bio评级，由优于大市调整至优于大市评级, 目标价由19.00美元调整至17.00美元。》资讯为影响Zura Bio Limited的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051221324394f481e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051221324394f481e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZURA"],"gpt_icon":0},{"id":"2534459634","title":"奥本海默：维持Zura Bio(ZURA.US)评级，由优于大市调整至优于大市评级, 目标价由19.00美元调整至17.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2534459634","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534459634?lang=zh_cn&edition=fundamental","pubTime":"2025-05-10 01:53","pubTimestamp":1746813181,"startTime":"0","endTime":"0","summary":"奥本海默：维持Zura Bio(ZURA.US)评级，由优于大市调整至优于大市评级, 目标价由19.00美元调整至17.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/10015350281249.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ZURA"],"gpt_icon":0},{"id":"2534395894","title":"祖拉生物有限公司公布截至 3 月 31 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2534395894","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534395894?lang=zh_cn&edition=fundamental","pubTime":"2025-05-09 22:56","pubTimestamp":1746802593,"startTime":"0","endTime":"0","summary":"祖拉生物有限公司公布截至 3 月 31 日的季度业绩 - 收益摘要Zura Bio Ltd ZURA.OQ报告了截至3月31日的季度调整后每股亏损19美分，低于去年同期的每股收益-2美分。八位分析师对该季度的平均预期是每股亏损 15 美分。该公司当季亏损 1744 万美元。Zura Bio Ltd 的股价本季度下跌了 2.3%，今年迄今为止下跌了 49.6%。华尔街对 Zura Bio Ltd 的 12 个月目标价中位数为 11.00 美元。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250509:nL4S3RH1M5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ZURA"],"gpt_icon":0},{"id":"2533637730","title":"Zura Bio Limited盘中异动 股价大跌5.56%报1.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533637730","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533637730?lang=zh_cn&edition=fundamental","pubTime":"2025-05-06 21:49","pubTimestamp":1746539378,"startTime":"0","endTime":"0","summary":"北京时间2025年05月06日21时49分，Zura Bio Limited股票出现异动，股价快速下挫5.56%。截至发稿，该股报1.36美元/股，成交量7622股，换手率0.01%，振幅3.65%。Zura Bio Limited股票所在的生物技术行业中，整体跌幅为3.94%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506214939a6d51cfd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506214939a6d51cfd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZURA"],"gpt_icon":0},{"id":"2533202500","title":"Zura Bio Ltd 预计每股亏损15美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2533202500","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533202500?lang=zh_cn&edition=fundamental","pubTime":"2025-05-06 18:33","pubTimestamp":1746527594,"startTime":"0","endTime":"0","summary":"Zura Bio Ltd 预计每股亏损15美分 - 财报前瞻) Zura Bio Ltd ZURA.OQ ZURA.O将于5月8日公布截至2025年3月31日的业绩(，预计季度收入不会有变化。LSEG的分析师平均预计Zura Bio Ltd每股亏损15美分。华尔街对 Zura Bio Ltd 的 12 个月目标价中位数为 11.00 美元，高于上一次收盘价 1.44 美元。5月6日 - 以前季度业绩。除非另有说明，否则所有数据均以美元为单位。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250506:nL4S3RE0Q6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZURA"],"gpt_icon":0},{"id":"2532054070","title":"Zura Bio Limited盘中异动 早盘股价大跌5.16%报1.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532054070","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532054070?lang=zh_cn&edition=fundamental","pubTime":"2025-05-01 21:33","pubTimestamp":1746106417,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日21时33分，Zura Bio Limited股票出现波动，股价快速下挫5.16%。截至发稿，该股报1.46美元/股，成交量1.0443万股，换手率0.02%，振幅2.60%。Zura Bio Limited股票所在的生物技术行业中，整体跌幅为1.22%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050121333794e9f668&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050121333794e9f668&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZURA"],"gpt_icon":0},{"id":"2532005008","title":"Zura Bio Limited盘中异动 大幅上涨5.04%报1.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532005008","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532005008?lang=zh_cn&edition=fundamental","pubTime":"2025-05-01 00:06","pubTimestamp":1746029178,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日00时06分，Zura Bio Limited股票出现异动，股价急速上涨5.04%。截至发稿，该股报1.46美元/股，成交量6.8253万股，换手率0.10%，振幅5.40%。Zura Bio Limited股票所在的生物技术行业中，整体涨幅为0.98%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050100061894e925c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050100061894e925c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZURA","BK4139"],"gpt_icon":0},{"id":"2530165923","title":"Zura Bio Limited盘中异动 下午盘快速跳水5.21%报1.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530165923","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530165923?lang=zh_cn&edition=fundamental","pubTime":"2025-04-26 01:31","pubTimestamp":1745602299,"startTime":"0","endTime":"0","summary":"北京时间2025年04月26日01时31分，Zura Bio Limited股票出现异动，股价大幅下挫5.21%。截至发稿，该股报1.37美元/股，成交量8.5209万股，换手率0.12%，振幅5.56%。Zura Bio Limited股票所在的生物技术行业中，整体涨幅为0.00%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504260131399745516b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504260131399745516b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZURA","BK4139"],"gpt_icon":0},{"id":"2529638768","title":"Zura Bio Limited盘中异动 急速上涨5.03%报1.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529638768","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529638768?lang=zh_cn&edition=fundamental","pubTime":"2025-04-23 22:19","pubTimestamp":1745417968,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日22时19分，Zura Bio Limited股票出现异动，股价大幅上涨5.03%。截至发稿，该股报1.57美元/股，成交量7.3408万股，换手率0.11%，振幅4.72%。Zura Bio Limited股票所在的生物技术行业中，整体涨幅为1.21%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423221929a464063a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423221929a464063a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZURA"],"gpt_icon":0},{"id":"2529653500","title":"Zura Bio Limited盘中异动 早盘大幅上涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529653500","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529653500?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 23:04","pubTimestamp":1745334246,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日23时04分，Zura Bio Limited股票出现异动，股价大幅拉升5.11%。截至发稿，该股报1.44美元/股，成交量9.8126万股，换手率0.14%，振幅7.28%。Zura Bio Limited股票所在的生物技术行业中，整体涨幅为1.62%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504222304079740d1b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504222304079740d1b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZURA","BK4139"],"gpt_icon":0},{"id":"2529800894","title":"Zura Bio Limited盘中异动 早盘急速上涨5.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529800894","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529800894?lang=zh_cn&edition=fundamental","pubTime":"2025-04-21 21:58","pubTimestamp":1745243937,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日21时58分，Zura Bio Limited股票出现波动，股价急速上涨5.69%。截至发稿，该股报1.30美元/股，成交量6.2215万股，换手率0.09%，振幅5.69%。Zura Bio Limited股票所在的生物技术行业中，整体跌幅为0.49%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421215857aa2c7418&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421215857aa2c7418&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZURA"],"gpt_icon":0},{"id":"2528262497","title":"Zura Bio Limited盘中异动 快速拉升5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528262497","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528262497?lang=zh_cn&edition=fundamental","pubTime":"2025-04-18 00:59","pubTimestamp":1744909164,"startTime":"0","endTime":"0","summary":"北京时间2025年04月18日00时59分，Zura Bio Limited股票出现异动，股价急速拉升5.04%。截至发稿，该股报1.21美元/股，成交量10.5142万股，换手率0.15%，振幅5.83%。Zura Bio Limited股票所在的生物技术行业中，整体涨幅为0.76%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418005924a6be3f51&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418005924a6be3f51&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZURA","BK4139"],"gpt_icon":0},{"id":"2527437334","title":"Zura Bio Limited盘中异动 股价大涨5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527437334","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527437334?lang=zh_cn&edition=fundamental","pubTime":"2025-04-15 22:09","pubTimestamp":1744726174,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日22时09分，Zura Bio Limited股票出现异动，股价大幅上涨5.35%。Zura Bio Limited股票所在的生物技术行业中，整体涨幅为0.36%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415220934aa2c6fed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415220934aa2c6fed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZURA"],"gpt_icon":0},{"id":"2527192429","title":"Zura Bio Limited盘中异动 股价大跌6.20%报1.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527192429","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527192429?lang=zh_cn&edition=fundamental","pubTime":"2025-04-14 23:47","pubTimestamp":1744645638,"startTime":"0","endTime":"0","summary":"北京时间2025年04月14日23时47分，Zura Bio Limited股票出现异动，股价急速跳水6.20%。截至发稿，该股报1.14美元/股，成交量4.5534万股，换手率0.07%，振幅5.36%。Zura Bio Limited股票所在的生物技术行业中，整体涨幅为2.00%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041423471894d52183&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041423471894d52183&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZURA"],"gpt_icon":0},{"id":"2526179196","title":"Zura Bio Limited盘中异动 股价大涨5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526179196","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526179196?lang=zh_cn&edition=fundamental","pubTime":"2025-04-12 03:09","pubTimestamp":1744398545,"startTime":"0","endTime":"0","summary":"北京时间2025年04月12日03时09分，Zura Bio Limited股票出现异动，股价大幅上涨5.36%。截至发稿，该股报1.18美元/股，成交量8.2693万股，换手率0.12%，振幅6.69%。Zura Bio Limited股票所在的生物技术行业中，整体涨幅为1.99%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412030905aa2c6d39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412030905aa2c6d39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZURA","BK4139"],"gpt_icon":0},{"id":"2526598332","title":"Zura Bio Limited盘中异动 股价大跌6.56%报1.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526598332","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526598332?lang=zh_cn&edition=fundamental","pubTime":"2025-04-10 21:32","pubTimestamp":1744291956,"startTime":"0","endTime":"0","summary":"北京时间2025年04月10日21时32分，Zura Bio Limited股票出现异动，股价急速下跌6.56%。截至发稿，该股报1.14美元/股，成交量2924股，换手率0.00%，振幅7.51%。Zura Bio Limited股票所在的生物技术行业中，整体跌幅为0.58%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410213236a455014d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410213236a455014d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZURA"],"gpt_icon":0},{"id":"2526311090","title":"Zura Bio Limited盘中异动 大幅上涨5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526311090","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526311090?lang=zh_cn&edition=fundamental","pubTime":"2025-04-10 01:21","pubTimestamp":1744219275,"startTime":"0","endTime":"0","summary":"北京时间2025年04月10日01时21分，Zura Bio Limited股票出现异动，股价大幅拉升5.31%。Zura Bio Limited股票所在的生物技术行业中，整体跌幅为0.92%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410012115a6b5a6d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410012115a6b5a6d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZURA","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":67,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ZURA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-08","symbol":"ZURA","fiscalQuarterEnding":"2025/03","expectedEps":-0.17,"name":null,"time":"盘前","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":-0.19},{"market":"US","date":"2025-03-25","symbol":"ZURA","fiscalQuarterEnding":"2024/12","expectedEps":-0.17,"name":null,"time":"盘前","type":"earning","dateTimestamp":1742875200000,"reportTimeType":"pre","actualEps":-0.08},{"market":"US","date":"2024-11-07","symbol":"ZURA","fiscalQuarterEnding":"2024/09","expectedEps":-0.14,"name":null,"time":"盘前","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-0.26},{"market":"US","date":"2024-08-13","symbol":"ZURA","fiscalQuarterEnding":"2024/06","expectedEps":-0.13,"name":null,"time":"盘前","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"pre","actualEps":-0.17},{"market":"US","date":"2024-05-09","symbol":"ZURA","fiscalQuarterEnding":"2024/03","expectedEps":-0.23,"name":null,"time":"盘前","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"pre","actualEps":-0.02}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ZURA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ZURA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4286,"buy":0.4286,"hold":0.1429,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4286,"analysts":7,"updateTime":1730779200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ZURA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ZURA","date":"2025-07-25","current":-1.673967,"percent":0.835897,"low":-19.645373,"twenty":-6.948723,"median":-3.46152,"eighty":-1.837853,"high":128.323671,"avg":-0.960888,"sd":19.096506,"marketCap":103949996},"quantilePoints":[{"date":"2023-03-17","current":6.722013,"twenty":3.077283,"median":4.444057,"eighty":5.810831,"marketCap":55244013},{"date":"2023-03-24","current":95.732999,"twenty":10.089418,"median":26.552728,"eighty":97.24286,"marketCap":786769586},{"date":"2023-03-31","current":115.825116,"twenty":24.157776,"median":96.676662,"eighty":121.414532,"marketCap":411078048},{"date":"2023-04-06","current":88.654345,"twenty":26.552728,"median":98.493858,"eighty":115.825116,"marketCap":314645530},{"date":"2023-04-14","current":87.334622,"twenty":54.797542,"median":97.620325,"eighty":115.825116,"marketCap":309961665},{"date":"2023-04-21","current":-9.744092,"twenty":23.559038,"median":92.924037,"eighty":110.2357,"marketCap":273592829},{"date":"2023-04-28","current":-7.850225,"twenty":-7.693221,"median":87.334622,"eighty":108.0657,"marketCap":220417184},{"date":"2023-05-05","current":-5.625705,"twenty":-7.58528,"median":65.049697,"eighty":103.1713,"marketCap":157957503},{"date":"2023-05-12","current":-8.54785,"twenty":-7.58528,"median":23.559038,"eighty":100.454223,"marketCap":240004959},{"date":"2023-05-19","current":-6.028363,"twenty":-7.236336,"median":-1.370145,"eighty":99.367392,"marketCap":169263255},{"date":"2023-05-26","current":-6.110447,"twenty":-6.948723,"median":-5.106395,"eighty":97.620325,"marketCap":171568003},{"date":"2023-06-02","current":-7.079022,"twenty":-6.974783,"median":-5.279277,"eighty":96.110464,"marketCap":198763468},{"date":"2023-06-09","current":-7.871872,"twenty":-7.497414,"median":-5.756178,"eighty":93.610039,"marketCap":221024977},{"date":"2023-06-16","current":-12.462533,"twenty":-7.876403,"median":-5.936326,"eighty":92.830881,"marketCap":349920722},{"date":"2023-06-23","current":-18.356145,"twenty":-8.029209,"median":-6.09739,"eighty":90.300117,"marketCap":515400472},{"date":"2023-06-30","current":-12.800188,"twenty":-8.465056,"median":-6.110447,"eighty":88.126456,"marketCap":359401332},{"date":"2023-07-07","current":-10.897043,"twenty":-9.736242,"median":-6.32748,"eighty":86.946468,"marketCap":305965163},{"date":"2023-07-14","current":-10.375213,"twenty":-10.301543,"median":-6.449998,"eighty":83.375453,"marketCap":291313310},{"date":"2023-07-21","current":-10.144993,"twenty":-10.16955,"median":-6.948723,"eighty":71.20099,"marketCap":284849257},{"date":"2023-07-28","current":-10.083602,"twenty":-10.362935,"median":-7.293596,"eighty":49.148579,"marketCap":283125510},{"date":"2023-08-04","current":-9.776643,"twenty":-10.464231,"median":-7.58528,"eighty":25.95399,"marketCap":274506773},{"date":"2023-08-11","current":-10.449013,"twenty":-10.439697,"median":-7.861048,"eighty":20.191633,"marketCap":293385452},{"date":"2023-08-18","current":-10.480065,"twenty":-10.545755,"median":-7.939831,"eighty":5.810831,"marketCap":294257326},{"date":"2023-08-25","current":-10.480065,"twenty":-10.559049,"median":-8.143707,"eighty":0.751603,"marketCap":294257326},{"date":"2023-09-01","current":-10.681903,"twenty":-10.607717,"median":-8.54785,"eighty":-4.921342,"marketCap":299924504},{"date":"2023-09-08","current":-4.570525,"twenty":-10.559388,"median":-8.166359,"eighty":-4.757501,"marketCap":287718274},{"date":"2023-09-15","current":-4.764426,"twenty":-10.559388,"median":-7.953905,"eighty":-4.66055,"marketCap":299924504},{"date":"2023-09-22","current":-4.258898,"twenty":-10.557695,"median":-7.871872,"eighty":-4.251973,"marketCap":268101119},{"date":"2023-09-29","current":-4.473574,"twenty":-10.542169,"median":-7.639251,"eighty":-4.258898,"marketCap":281615159},{"date":"2023-10-06","current":-4.757501,"twenty":-10.497996,"median":-7.350856,"eighty":-4.283136,"marketCap":299488567},{"date":"2023-10-13","current":-4.383549,"twenty":-10.495591,"median":-7.013872,"eighty":-4.383549,"marketCap":275947981},{"date":"2023-10-20","current":-3.573319,"twenty":-10.495591,"median":-6.455254,"eighty":-4.196573,"marketCap":224943378},{"date":"2023-10-27","current":-3.573319,"twenty":-10.490414,"median":-6.444741,"eighty":-4.161948,"marketCap":224943378},{"date":"2023-11-03","current":-3.414044,"twenty":-10.481615,"median":-6.238867,"eighty":-3.923726,"marketCap":214916832},{"date":"2023-11-10","current":-2.956991,"twenty":-10.480065,"median":-6.108894,"eighty":-3.419584,"marketCap":186145005},{"date":"2023-11-17","current":-2.648491,"twenty":-10.467644,"median":-5.982344,"eighty":-3.254768,"marketCap":185709068},{"date":"2023-11-24","current":-2.791485,"twenty":-10.449013,"median":-5.807949,"eighty":-3.105187,"marketCap":195735614},{"date":"2023-12-01","current":-3.015301,"twenty":-10.439697,"median":-5.625705,"eighty":-2.958376,"marketCap":211429338},{"date":"2023-12-08","current":-2.486846,"twenty":-10.40006,"median":-5.130482,"eighty":-2.892202,"marketCap":174374712},{"date":"2023-12-15","current":-2.611189,"twenty":-10.387491,"median":-4.906391,"eighty":-2.779051,"marketCap":183093447},{"date":"2023-12-22","current":-3.183163,"twenty":-10.362935,"median":-4.840601,"eighty":-2.781538,"marketCap":223199631},{"date":"2023-12-29","current":-2.984215,"twenty":-10.326099,"median":-4.826751,"eighty":-2.788998,"marketCap":209249654},{"date":"2024-01-05","current":-2.517932,"twenty":-10.262321,"median":-4.816363,"eighty":-2.775321,"marketCap":176554395},{"date":"2024-01-12","current":-2.443326,"twenty":-10.181318,"median":-4.764426,"eighty":-2.706932,"marketCap":171323154},{"date":"2024-01-19","current":-2.505498,"twenty":-10.172619,"median":-4.757501,"eighty":-2.649734,"marketCap":175682522},{"date":"2024-01-26","current":-2.238162,"twenty":-10.157271,"median":-4.695176,"eighty":-2.617406,"marketCap":156937240},{"date":"2024-02-02","current":-1.933523,"twenty":-10.132715,"median":-4.639775,"eighty":-2.529123,"marketCap":135576338},{"date":"2024-02-09","current":-2.437109,"twenty":-10.071324,"median":-4.573987,"eighty":-2.500524,"marketCap":170887217},{"date":"2024-02-16","current":-2.493063,"twenty":-10.01914,"median":-4.570525,"eighty":-2.486846,"marketCap":174810648},{"date":"2024-02-23","current":-2.275464,"twenty":-10.006862,"median":-4.432024,"eighty":-2.486846,"marketCap":159552861},{"date":"2024-03-01","current":-2.287899,"twenty":-9.776643,"median":-4.271017,"eighty":-2.449544,"marketCap":160424735},{"date":"2024-03-08","current":-2.001911,"twenty":-9.745947,"median":-4.196573,"eighty":-2.424675,"marketCap":140371643},{"date":"2024-03-15","current":-1.970826,"twenty":-9.744092,"median":-4.127323,"eighty":-2.35007,"marketCap":138191959},{"date":"2024-03-22","current":-1.796746,"twenty":-9.744092,"median":-3.981897,"eighty":-2.287899,"marketCap":125985729},{"date":"2024-03-28","current":-1.675569,"twenty":-9.733298,"median":-3.573319,"eighty":-2.275464,"marketCap":101137332},{"date":"2024-04-05","current":-2.094461,"twenty":-9.709993,"median":-3.420969,"eighty":-2.199615,"marketCap":126421666},{"date":"2024-04-12","current":-2.072794,"twenty":-9.700891,"median":-3.379418,"eighty":-2.090128,"marketCap":125113855},{"date":"2024-04-19","current":-2.665021,"twenty":-9.687625,"median":-3.254768,"eighty":-2.111795,"marketCap":160860671},{"date":"2024-04-26","current":-3.737907,"twenty":-9.574049,"median":-3.270203,"eighty":-2.116128,"marketCap":225620043},{"date":"2024-05-03","current":-4.502009,"twenty":-9.49731,"median":-3.407119,"eighty":-2.159044,"marketCap":271741268},{"date":"2024-05-10","current":-4.89959,"twenty":-8.765356,"median":-3.41781,"eighty":-2.190413,"marketCap":286699503},{"date":"2024-05-17","current":-6.390769,"twenty":-8.555367,"median":-3.573319,"eighty":-2.204775,"marketCap":373955874},{"date":"2024-05-24","current":-6.007323,"twenty":-8.382261,"median":-3.737907,"eighty":-2.231945,"marketCap":351518521},{"date":"2024-05-31","current":-5.591923,"twenty":-8.236161,"median":-3.981897,"eighty":-2.251609,"marketCap":327211389},{"date":"2024-06-07","current":-4.271164,"twenty":-8.139176,"median":-4.127323,"eighty":-2.264907,"marketCap":249927175},{"date":"2024-06-14","current":-4.015533,"twenty":-8.029209,"median":-4.079441,"eighty":-2.268667,"marketCap":234968940},{"date":"2024-06-21","current":-3.642739,"twenty":-7.95672,"median":-4.015533,"eighty":-2.271734,"marketCap":213154848},{"date":"2024-06-28","current":-3.727949,"twenty":-7.921709,"median":-3.977412,"eighty":-2.275464,"marketCap":218140926},{"date":"2024-07-05","current":-3.727949,"twenty":-7.889994,"median":-3.928937,"eighty":-2.276707,"marketCap":218140926},{"date":"2024-07-12","current":-4.041687,"twenty":-7.867543,"median":-3.951626,"eighty":-2.282925,"marketCap":236499340},{"date":"2024-07-19","current":-3.802019,"twenty":-7.818824,"median":-3.919672,"eighty":-2.287899,"marketCap":222475120},{"date":"2024-07-26","current":-4.23778,"twenty":-7.671633,"median":-3.972928,"eighty":-2.290386,"marketCap":247973702},{"date":"2024-08-02","current":-3.965429,"twenty":-7.563313,"median":-3.977412,"eighty":-2.30282,"marketCap":232037088},{"date":"2024-08-09","current":-3.693078,"twenty":-7.450529,"median":-3.972928,"eighty":-2.317741,"marketCap":216100475},{"date":"2024-08-16","current":-6.331005,"twenty":-7.327952,"median":-3.982738,"eighty":-2.340122,"marketCap":220439248},{"date":"2024-08-23","current":-6.480637,"twenty":-7.204873,"median":-4.015533,"eighty":-2.355044,"marketCap":225649304},{"date":"2024-08-30","current":-7.497208,"twenty":-7.492856,"median":-4.025346,"eighty":-2.376181,"marketCap":261045273},{"date":"2024-09-06","current":-6.630361,"twenty":-7.475447,"median":-4.052581,"eighty":-2.381155,"marketCap":230862542},{"date":"2024-09-13","current":-6.776887,"twenty":-7.472893,"median":-4.085772,"eighty":-2.387372,"marketCap":235964443},{"date":"2024-09-20","current":-8.132265,"twenty":-7.497208,"median":-4.101605,"eighty":-2.390574,"marketCap":283157332},{"date":"2024-09-27","current":-7.454576,"twenty":-7.497208,"median":-4.139734,"eighty":-2.424675,"marketCap":259560888},{"date":"2024-10-04","current":-8.022369,"twenty":-7.564472,"median":-4.172629,"eighty":-2.426686,"marketCap":279330882},{"date":"2024-10-11","current":-7.43626,"twenty":-7.58528,"median":-4.207257,"eighty":-2.437109,"marketCap":258923146},{"date":"2024-10-18","current":-9.011429,"twenty":-7.619419,"median":-4.255435,"eighty":-2.443326,"marketCap":313768936},{"date":"2024-10-25","current":-8.681742,"twenty":-7.710999,"median":-4.283136,"eighty":-2.443326,"marketCap":302289584},{"date":"2024-11-01","current":-8.022369,"twenty":-7.871872,"median":-4.341273,"eighty":-2.449544,"marketCap":279330882},{"date":"2024-11-08","current":-6.328847,"twenty":-7.875842,"median":-4.409078,"eighty":-2.461978,"marketCap":299044367},{"date":"2024-11-15","current":-4.366628,"twenty":-7.871872,"median":-4.447456,"eighty":-2.468195,"marketCap":206327554},{"date":"2024-11-22","current":-3.772435,"twenty":-7.850225,"median":-4.409078,"eighty":-2.474412,"marketCap":178251336},{"date":"2024-11-29","current":-4.214625,"twenty":-7.812108,"median":-4.379403,"eighty":-2.484359,"marketCap":199145266},{"date":"2024-12-06","current":-3.979712,"twenty":-7.747073,"median":-4.327977,"eighty":-2.486846,"marketCap":188045366},{"date":"2024-12-13","current":-3.150605,"twenty":-7.715439,"median":-4.283136,"eighty":-2.486846,"marketCap":148869248},{"date":"2024-12-20","current":-3.150605,"twenty":-7.696777,"median":-4.255435,"eighty":-2.486846,"marketCap":148869248},{"date":"2024-12-27","current":-3.454611,"twenty":-7.692898,"median":-4.233112,"eighty":-2.486846,"marketCap":163233825},{"date":"2025-01-03","current":-3.565159,"twenty":-7.679844,"median":-4.210941,"eighty":-2.489333,"marketCap":168457307},{"date":"2025-01-10","current":-2.984784,"twenty":-7.652352,"median":-4.189941,"eighty":-2.494306,"marketCap":141034024},{"date":"2025-01-17","current":-2.445865,"twenty":-7.615756,"median":-4.161948,"eighty":-2.488469,"marketCap":115569548},{"date":"2025-01-24","current":-2.376772,"twenty":-7.601103,"median":-4.145533,"eighty":-2.486846,"marketCap":112304871},{"date":"2025-01-31","current":-2.597867,"twenty":-7.587973,"median":-4.117946,"eighty":-2.474412,"marketCap":122751836},{"date":"2025-02-07","current":-2.293862,"twenty":-7.58528,"median":-4.092697,"eighty":-2.461978,"marketCap":108387259},{"date":"2025-02-14","current":-2.141859,"twenty":-7.564472,"median":-4.071459,"eighty":-2.445865,"marketCap":101204971},{"date":"2025-02-21","current":-1.934582,"twenty":-7.535166,"median":-4.045246,"eighty":-2.436096,"marketCap":91410942},{"date":"2025-02-28","current":-1.879308,"twenty":-7.503334,"median":-4.019899,"eighty":-2.390588,"marketCap":88799200},{"date":"2025-03-07","current":-1.741124,"twenty":-7.479799,"median":-4.012269,"eighty":-2.376772,"marketCap":82269847},{"date":"2025-03-14","current":-1.768761,"twenty":-7.473404,"median":-3.98358,"eighty":-2.360377,"marketCap":83575718},{"date":"2025-03-21","current":-1.920764,"twenty":-7.458239,"median":-3.97632,"eighty":-2.299039,"marketCap":90758006},{"date":"2025-03-28","current":-1.650561,"twenty":-7.439923,"median":-3.965429,"eighty":-2.286655,"marketCap":86494372},{"date":"2025-04-04","current":-1.343935,"twenty":-7.43626,"median":-3.888445,"eighty":-2.268957,"marketCap":70426247},{"date":"2025-04-11","current":-1.578798,"twenty":-7.43626,"median":-3.869164,"eighty":-2.22123,"marketCap":82733747},{"date":"2025-04-17","current":-1.604894,"twenty":-7.385018,"median":-3.866416,"eighty":-2.158607,"marketCap":84101247},{"date":"2025-04-25","current":-1.787565,"twenty":-7.336161,"median":-3.851042,"eighty":-2.091311,"marketCap":93673747},{"date":"2025-05-02","current":-1.918044,"twenty":-7.319952,"median":-3.834462,"eighty":-2.07178,"marketCap":100511247},{"date":"2025-05-09","current":-1.205655,"twenty":-7.300111,"median":-3.807466,"eighty":-2.049161,"marketCap":74868747},{"date":"2025-05-16","current":-1.106014,"twenty":-7.278743,"median":-3.786254,"eighty":-2.016502,"marketCap":68681247},{"date":"2025-05-23","current":-1.036265,"twenty":-7.271417,"median":-3.738253,"eighty":-2.007994,"marketCap":64349997},{"date":"2025-05-30","current":-1.016337,"twenty":-7.257385,"median":-3.729465,"eighty":-1.994142,"marketCap":63112497},{"date":"2025-06-06","current":-1.14587,"twenty":-7.235716,"median":-3.693078,"eighty":-1.973826,"marketCap":71156247},{"date":"2025-06-13","current":-1.215619,"twenty":-7.20548,"median":-3.669367,"eighty":-1.948401,"marketCap":75487497},{"date":"2025-06-20","current":-1.106014,"twenty":-7.150532,"median":-3.621436,"eighty":-1.94414,"marketCap":68681247},{"date":"2025-06-27","current":-1.14587,"twenty":-7.101064,"median":-3.600133,"eighty":-1.923316,"marketCap":71156247},{"date":"2025-07-03","current":-1.125942,"twenty":-7.079022,"median":-3.589482,"eighty":-1.914872,"marketCap":69918747},{"date":"2025-07-11","current":-1.385008,"twenty":-7.069942,"median":-3.569239,"eighty":-1.8789,"marketCap":86006247},{"date":"2025-07-18","current":-1.952961,"twenty":-7.051626,"median":-3.482969,"eighty":-1.86549,"marketCap":121274996},{"date":"2025-07-25","current":-1.673967,"twenty":-6.948723,"median":-3.46152,"eighty":-1.837853,"marketCap":103949996}],"updateTime":1753601447331}}}